Non-linear dose-response of DNA-reactive genotoxins: Recommendations for data analysis

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 678, Issue 2, 2009, Pages 95-100

  Johnson, George E ^a   Doak, Shareen H ^a   Griffiths, Sioned M ^a   Quick, Emma L ^a   Skibinski, David O F ^a   Zaïr, Zoulikha M ^a   Jenkins, Gareth J ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

DNA reactive; Dose response; EMS; Genotoxic; MMS; Threshold

Indexed keywords

DNA; TOXIN;

ARTICLE; ASSAY; CONTROLLED STUDY; DATA ANALYSIS; DOSE RESPONSE; HUMAN; HUMAN CELL; LINEAR REGRESSION ANALYSIS; MUTATION; PRIORITY JOURNAL; STATISTICAL MODEL;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LINEAR MODELS; MODELS, STATISTICAL; MUTAGENS; NO-OBSERVED-ADVERSE-EFFECT LEVEL; RISK ASSESSMENT; THRESHOLD LIMIT VALUES;

EID: 69449087034     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2009.05.009     Document Type: Article

References (22)

1. Speit G., Autrup H., Crebelli R., Henderson L., Kirsch-Volders M., Madle S., Parry J.M., Sarrif A.M., and Vrijhof H. Thresholds in genetic toxicology-concluding remarks. Mutat. Res. 464 (2000) 149-153
2. Elhajouji A., Tibaldi F., and Kirsch-Volders M. Indication for thresholds of chromosome non-disjunction versus chromosome lagging induced by spindle inhibitors in vitro in human lymphocytes. Mutagenesis 12 (1997) 133-140
3. Elhajouji A., Van Hummelen P., and Kirsch-Volders M. Indications for a threshold of chemically-induced aneuploidy in vitro in human lymphocytes. Environ. Mol. Mutagen. 26 (1995) 292-304
4. Johnson G.E., and Parry E.M. Mechanistic investigations of low dose exposures to the genotoxic compounds bisphenol-A and rotenone. Mutat. Res. 651 (2008) 56-63
5. Doak S.H., Jenkins G.J., Johnson G.E., Quick E., Parry E.M., and Parry J.M. Mechanistic influences for mutation induction curves after exposure to DNA-reactive carcinogens. Cancer Res. 67 (2007) 3904-3911
6. Swenberg J.A., Fryar-Tita E., Jeong Y.-C., Boysen G., Starr T., Walker V.E., and Albertini R.J. Biomarkers in toxicology and risk assessment: informing critical dose-response relationships. Chem. Res. Toxicol. 21 (2008) 253-265
7. COT Interdepartmental Group on Health Risks From Chemicals (IGHRC) Draft Guidelines Document on "Chemical Mixtures: A Framework for Assessing Risks", Report TOX/2007/19, Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment, London, UK, 2007. Available at: http://cot.food.gov.uk/.
8. Lutz W.K., and Lutz R.W. Statistical model to estimate a threshold dose and its confidence limits for the analysis of sublinear dose-response relationships, exemplified for mutagenicity data. Mutat. Res. 678 (2009) 118-122
9. Bolt H.M., Foth H., Hengstler J.G., and Degen G.H. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective*1. Toxicol. Lett. 151 (2004) 29-41
10. Parry J.M., Jenkins G.J., Haddad F., Bourner R., and Parry E.M. In vitro and in vivo extrapolations of genotoxin exposures: consideration of factors which influence dose-response thresholds. Mutat. Res. 464 (2000) 53-63
11. Kirsch-Volders M., Aardema M., and Elhajouji A. Concepts of threshold in mutagenesis and carcinogenesis. Mutat. Res. 464 (2000) 3-11
12. Müller L., Mauthe R.J., Riley C.M., Andino M.M., Antonis D.D., Beels C., DeGeorge J., De Knaep A.G., Ellison D., Fagerland J.A., Frank R., Fritschel B., Galloway S., Harpur E., Humfrey C.D., Jacks A.S., Jagota N., Mackinnon J., Mohan G., Ness D.K., O'Donovan M.R., Smith M.D., Vudathala G., and Yotti L. A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity. Regul. Toxicol. Pharmacol. 44 (2006) 198-211
13. Ellinger-Ziegelbauer H., Stuart B., Wahle B., Bomann W., and Ahr H.J. Characteristic expression profiles induced by genotoxic carcinogens in rat liver. Toxicol. Sci. 77 (2004) 19-34
14. Jenkins G.J., Doak S.H., Johnson G.E., Quick E., Waters E.M., and Parry J.M. Do dose response thresholds exist for genotoxic alkylating agents?. Mutagenesis 20 (2005) 389-398
15. Doak S.H., Brüsehafer K., Dudley E., Quick E., Johnson G., Newton R.P., and Jenkins G.J.S. No-observed effect levels are associated with up-regulation of MGMT following MMS exposure. Mutat. Res. 648 (2008) 9-14
16. Kirkland D.K. Basic Mutagenicity Tests: UKEMS Recommended Procedures (1990), Cambridge University Press
17. IGHRC, Assessment of chemical carcinogens: background to general principles and weight of evidence approach, Report of the Interdepartmental Group on Health Risks from Chemicals, MRC Institute for Environment and Health, University of Leicester, UK, 2002. Available at: http://ieh.cranfield.ac.uk/ighrc/ighrc.html.
18. Ashby J., and Styles J.A. Does carcinogenic potency correlate with mutagenic potency in the Ames assay?. Nature 271 (1978) 452-455
19. Gocke E., Ballantyne M., Whitwell J., and Müller L. MNT and Muta(TM) Mouse studies to define the in vivo dose response relations of the genotoxicity of EMS and ENU. Toxicol. Lett. (2009) 10.1016/j.toxlet.2009.03.021
20. Gocke E., and Müller L. In vivo studies in the mouse to define a threshold for the genotoxicity of EMS and ENU. Mutat Res. 678 (2009) 101-107
21. Gocke E., and Wall M. In vivo genotoxicity of EMS: statistical assessment of the dose response curves. Toxicol. Lett. (2009) 10.1016/j.toxlet.2009.03.008
22. Müller L., Gocke E., Lavé T., and Pfister T. Ethyl methanesulfonate toxicity in Viracept-a comprehensive human risk assessment based on threshold data for genotoxicity. Toxicol. Lett. (2009) 10.1016/j.toxlet.2009.04.003